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Background/aim: This study investigated the effect of Ginkgo biloba (GB) on brain volume in cerebral ischemia induced by stopping
carotid artery blood flow.
Materials and methods: Twenty-four adult male rats were divided into 4 groups of 6 rats each. No procedure was performed on the
control group. Ischemia was applied to the rats in the ischemia and ischemia + GB groups by clamping the arteria carotis communis for
30 min. The rats in the ischemia + GB group were given 100 mg/kg drops (Tebokan Fort Drop, Abdi İbrahim İlaç Sanayi A.Ş., Turkey)
containing dry GB leaf extract orally, every day for 14 days from the day of ischemia. In the sham group, surgical stress alone was applied
by performing a skin incision. On the 14th day, brain tissues were extracted and evaluated stereologically and histopathologically.
Results: The only statistically significant difference was observed between the sham and control groups.
Conclusion: This result may be interpreted as surgical stress, established by cutaneous incision, having an adverse effect on brain
volume. Additionally, the absence of any difference in terms of brain volume following 30 min of ischemia between the ischemia and
control groups suggests that a probable postischemic rise in brain volume disappears within 14 days.
Key words: Ginkgo biloba, brain, ischemia, rat, stereology

1. Introduction
Ischemia, defined as a decrease in or complete stoppage
of blood flow to a tissue for a specific duration, leads to
exceedingly serious clinical pathological events and the
emergence of several irreversible findings (1). Ischemia
can appear for various reasons in any tissue or organ
with arterial blood flow. Ischemia may develop due to
mechanical or physical effects such as cuts or pressure
arising in the arterial system, and structural variations
gradually developing in arteries via various agents can
also lead to it. Ischemia resulting from coronary artery
diseases may give rise to significant consequences in the
brain. Brain damage and severe neurological function
defects arising in association with this are among the most
important consequences of cerebral ischemia (2).
Central nervous system (CNS) tissues such as the
brain, cerebellum, and medulla are known to be more
sensitive to ischemia than other tissues. For example,
* Correspondence: eodaci@gmail.com
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the brain has a high metabolic rate and low-oxygen and
high-energy phosphate or carbohydrate reserves, making
it more sensitive to ischemia (3). The cerebellum and
some parts of the hippocampus and thalamus are also
CNS tissues with considerable sensitivity to ischemia. This
sensitivity also leads to serious neurological, pathological,
and psychological events that directly affect human life
and can result in death or reduced quality of life.
The mechanism involved in ischemic injury has largely
been explained. Understanding the mechanism of ischemic
injury has led to an increase in studies aimed at eliminating
or reducing the likely consequences of ischemia. Another
important reason for this rise is that the results obtained
by establishing experimental ischemic models in animals
have been shown to be applicable in clinical practice (4).
Free oxygen radicals (FORs) form as the result of
excessive adenosine triphosphate (ATP) depletion in
tissues with inadequate oxygenation due to ischemia or for
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some other reason. Due to their unshared electrons, FORs
are very reactive and enter into reaction with important
biological structures such as cell lipids, proteins, DNA,
carbohydrates, and enzymes. There is therefore convincing
evidence that FORs represent the main source of tissue
damage (5). A significant part of the studies on the subject
have focused on reducing or preventing the formation of
FORs resulting from ischemia. Studies have investigated
changes in the chemical structures of existing drugs used
in treatment or the development of new drugs for that
purpose, while there are also studies regarding various
plant essences found in nature. One of the most important
of these plants is Ginkgo biloba (GB) (6–8).
GB originates from Asia and has long been used in
the treatment of numerous diseases in that region. Also
known as the Japanese plum, GB is cultivated in various
regions of China (9). GB leaves and seeds are known to
have been used some 5000 years ago in traditional Chinese
medicine in the treatment of asthma, coughs, bronchitis,
and incontinence (10). GB has proven benefits in cerebral
and peripheral blood flow disorders. Thanks to the
flavonoids it contains, GB extract possesses powerful free
radical-binding properties and is regarded as a temporary
antioxidant that can be used in the correction of ischemiarelated reduced blood flow and damage caused by resulting
FORs (5). However, our scan of the literature revealed
insufficient studies investigating the effect of GB on
ischemia-associated brain damage. This study on cerebral
ischemia induced by the occlusion of arteria carotis blood
flow in rats investigated the effect of GB on brain volume
using stereological techniques (11–13).
2. Materials and methods
2.1. Animals and ethics
Twenty-four 16-week-old male Sprague Dawley rats, each
weighing 270–300 g, were used. Animals were obtained
from Karadeniz Technical University (KTU) Surgery
Research Center (SRC). Rats were divided into 4 groups:
Group I (control group, n = 6), Group II (ischemia group,
n = 6), Group III (ischemia + GB group, n = 6), and
Group IV (sham group, n = 6). The rats for each group
were selected at random and monitored in separate cages
throughout the study. No procedure was performed on
the rats in Group I, the control group. Thirty minutes of
ischemia was applied to the rats in Groups II and III. No
further procedure was performed on Group II rats except
for ischemia induction, and these rats were monitored for
14 days.
Animal experiments and procedures were performed
in accordance with the Guide for the Care and Use
of Laboratory Animals published by the US National
Institutes of Health (14). The KTU Medical Faculty’s Local
Ethics Committee approved all animal procedures and
experiments (Date: 26.10.2010; Decision No.: 3). During

the experimental procedures, rats were housed in the
KTU SRC in standard plastic cages on sawdust bedding
in an air-conditioned room at 22 ± 1 °C under controlled
lighting (cycles of 12 h light/12 h dark). Standard rat chow
and tap water were given ad libitum. The groups were kept
in different cages in the same room during the experiment.
2.2. Ginkgo biloba treatment
Drops containing dry GB leaf extract (EGb 761, 100 mg/
kg; Tebokan Fort Drop, Abdi İbrahim İlaç Sanayi A.Ş.,
Turkey) were administered orally to the rats in Group III,
once a day at the same time for 14 days, beginning on the
day of ischemia induction. A gavage needle was used for
this purpose. The rats were held by the skin at the back
of the neck. Extension was established by retracting the
head. The gavage needle was passed between the teeth.
The needle was rotated slightly to facilitate entry to the
esophagus and stomach and passed over the tongue. When
the pharynx was reached, the gavage needle entered the
esophagus due to the swallowing reflex and the drops
containing GB were deposited in the stomach. Only skin
incision and suturing were performed to the neck regions
of the rats in Group IV.
2.3. Ischemia procedures
At the beginning of the ischemia procedures, rats were
anesthetized with urethane at 1.25 g/kg, administered
intraperitoneally. They were placed on a surgical table on
their backs with their heads extended and feet fixed to the
table. Anterior neck regions were shaved and cleaned with
İsosol antiseptic solution (polyvinylpyrrolidone iodine
10%, Merkez Lab., Turkey). A 2-cm vertical incision was
made down the center of the anterior neck region. The
incision was opened laterally with the help of a retractor, in
such a way as not to damage the skin tissues. The right and
left carotid arteries were accessed, again without damaging
the tissues and vessels in the incision region. In order to
clamp the internal carotid arteries effectively, the neck skin
fascia in the dorsal parts was isolated from the prevertebral
neck muscles (15).
In Groups II and III, blood flow was halted by clamping
both arteries simultaneously using Yaşargil aneurysm
clamps (BA045). Cerebral ischemia was induced by
interrupting blood flow to the brain for 30 min. During
this time the incision and ischemia sites were prevented
from drying out by moistening the exposed surgical sites
with isotonic solution. Vital findings such as respiration
and heartbeat were monitored constantly. Clamps were
removed after 30 min. The incision region was then
sutured, with care being taken over circulation and tissue
positions. In Group IV, incision alone was performed,
following anesthesia, as described above. No procedure
was performed on the rats in Group I. Rats were monitored
for 14 days following surgery. GB was administered orally
to the rats in Group III at the same time every day, between
1100 and 1200 hours (15).
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2.4. Histological procedures
One rat from Group II died for an undetermined reason
on the second day following ischemia, and 1 rat from
Group III died due to aspiration during administration
of GB. The study was thus completed with 22 rats, 6 each
in Groups I and IV and 5 each in Groups II and III. On
the 14th day, all rats were perfused and their brains and
cerebellum were removed and separated from each other.
Brain tissues were coded and numbered. Tissues were
kept in formaldehyde for 10 days and then embedded in
paraffin. Sections were taken and subjected to routine
histopathological techniques.
2.5. Section preparation and staining
The basic principles of stereology were followed at
this stage of the study. Preliminary investigation was
performed and the thickness of the sections to be subjected
to stereological analysis and the section sampling fraction
(SSF) were determined. Section thickness was determined
as 30 µm and the SSF, identified using systematic random
sampling, was calculated at 1/10 (Table 1). The preliminary
study results were compared with those from the literature.
Our scan of the literature revealed that a sampling fraction
of 1/10 and sections of 26–40 µm in thickness had been
used in similar studies (15–22). The main study was
thus performed on a 1/10 section sample on the basis of
30-µm-thick sections. Sections were prepared with the
help of a fully automatic microtome (Leica RM 2255,
Leica Instruments, Nußloch, Germany), using disposable
metal microtome blades (Leica 819, Leica Instruments).
At the end of the preparation procedure, 40–49 sections
were obtained from each animal. Staining was performed
following section preparation using 0.1% cresyl fast violet.
Brain volume for each rat was calculated from the sections
obtained using a stereological analysis system housed in
the KTU Faculty of Medicine’s Department of Histology
and Embryology Stereology Laboratory.
2.6. Stereology analysis system
The stereological analysis system housed in the KTU
Faculty of Medicine’s Department of Histology and

Embryology Stereology Laboratory contains stereology
analysis software and equipment manufactured by
Leica. The system consists of a computer (Pentium
PC, DELL OptiPlex, USA) containing stereology
analysis software designed by MicroBrightField (USA),
a research microscope (Leica, DM4000B-M), a CCD
camera (JVC, Japan), a measuring rod measuring in the
Z axis (Heidenhain LIP401 R, Germany), a microcator
(Heidenhain ND 221 B), a computer-controlled motorized
table capable of directing controlled movement in the X
and Y axes of the microscope table (Prior ProScan, USA),
a joystick (Prior, USA), and a power source.
Stereological investigations can be performed with
simple equipment and materials capable of being mounted
on a light microscope in many laboratories. However,
because of their speed and relatively high reliability,
computer-assisted stereological analysis systems and
software are becoming increasingly widespread in
institutions in which research is conducted using
stereological techniques. The margins and area of the
structure being investigated, random area sampling,
and consecutive scanning of sampled areas can be easily
studied in stereological analysis systems (15,21–23).
2.7. Stereological analysis details
The stereological analysis system was recalibrated every
day throughout the study and thus functioned with
minimal error. In order to calculate volume with the
area calculation method, 1 out of each of the 10 sections
previously chosen using systematic random sampling
(SSF = 1/10) was examined and area calculations were
performed. In brief, the following procedures were
performed: first, the Stereoinvestigator program in the
stereological analysis system was turned on. The section
whose brain area was to be calculated was inserted into the
microscope. The area was located using the microscope’s
2.5× lens and the image was focused using micro- and
macroscrews. To measure the area, the right-click button
on the mouse was held down over the image and the
‘Continuous Talking’ option was selected from the menu.

Table 1. Sampling strategy used for stereological analysis.
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Analysis parameters

Values

Section sampling fraction (SSF)

1/10

Sampled sections from each rat brain (min–max)

40–49

Paraffin section thickness (µm)

30

Sampled section thickness for volume estimation (µm; min–max)

20.4–23.67

Objective lens for area calculation

2.5

Objective lens for thickness calculation

100
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The outline of the area to be measured was then traced.
Once the outline was traced, the right-click button was
pressed again and the ‘Close Contour’ option was selected
to measure the area thus enclosed. Area was calculated in
the same way for each section. The areas of all sections
were then added to give a total figure for all the sections
from one rat brain.
We then measured the thickness of the sections
sampled. During thickness measurement, lens
magnification in both the system and the microscope
was raised to 100×. The image was focused by dropping
immersion oil onto it. When the image was clear, this was
taken as the upper surface of the section, and the value
determined by the microcator was recorded. Progression
then took place from the upper surface to the lower with
the help of a microscrew. When clarity of image was lost,
this was regarded as the lower margin of the section and
the value shown by the microcator at this level was again
recorded. The difference between the 2 values was taken
as section thickness. Thicknesses of the sections sampled
in this way were thus determined, means were taken,
and a mean thickness for the sections belonging to that
individual was thus established.
Following all these procedures conducted with the
Stereoinvestigator program, the following formula was
used to calculate total brain volume in one rat:
Vtotal = ∑ Ai .t .1/ SSF
where Vtotal represents brain volume in one individual,
Σ Ai the total area in the sections sampled, t the mean
thickness of the sections sampled, and SSF the section
sampling fraction. SSF was determined at 1/10 (Table 1).
In summary, the total section areas were multiplied by
the mean section thickness to give the volume of sections
sampled (Figure 1). The total brain volume was calculated
by multiplying the volume determined by the sampling
fraction (11–13,24).
2.8. Statistical analysis
Pre- and poststudy rat weights were analyzed using
ANOVA (t-test) and Tukey’s test. Study group brain
volumes and weights were compared using the Kruskal–
Wallis test. Statistical analyses were performed with SPSS
13.1 (SPSS Inc., Chicago, IL, USA). Results are expressed
as mean ± SEM. A P-value of less than 0.05 was considered
statistically significant.
3. Results
3.1. Morphological changes in brain neurons
Histopathological analysis of rat brain neurons revealed
no significant differences between neurons in Groups

Vtotal= V1 + V2 + V3 + V4 + V5 + V6

t

A6

V6

t

A5

V5

t

A4

V4

t

t

Area measured
using calibrated
software

A3

V3
V2

t

A2
A1
V1 =A 1 x t

t = section thickness
A = area
V = volume

Figure 1. Volume calculation showing the application of the
stereological principle. According to the stereological principle,
the structure of interest is cut from end to end with a series of
parallel plane sections at a constant distance. In this study, area
was measured for each section using Stereoinvestigator program
calibrated software. Following procedures conducted in the
Stereoinvestigator program, volume was calculated using V = A
× t for each section.

I (Figure 2A), II (Figure 2B), III (Figure 2C), and IV
(Figure 2D). Neurons in Groups II, III, and IV were not
morphologically different from those in Group I, and
there were no damaged neurons (i.e. black or shrunken
perikaryon) in Groups II, III, and IV in comparison with
Group I.
3.2. Body and brain weight findings
Data for pre- and poststudy group weights are shown in
Table 2. Prestudy ANOVA (t-test) revealed that rats used
in all groups were similar, and the Tukey test revealed that
there were no differences between the groups. Rats were
evaluated in terms of weight at the end of the study, and no
statistically significant difference was determined between
the groups. Statistical analysis of rat brain weights obtained
at the end of the study again revealed no significant
difference among the groups (P < 0.05) (Table 2).
3.3. Brain volume results
Statistical analysis of rat brain volumes revealed no
significant difference among Groups I, II, and III. However,
a significant difference was determined between Groups I
and IV (P = 0.009) (Table 3).
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Figure 2. Representative light microscopic photomicrographs of rat brain belong to the control (A), ischemia (B), ischemia +
GB (C), and sham (D) groups (stain: cresyl fast violet). There were no damaged neurons (i.e. black or shrunken perikaryon) in
the ischemia and ischemia + GB groups’ brain after the 30 min of bilateral carotid artery occlusion (B, C) in comparison with
the control and sham groups (A, D). It should be noted that the absence of any difference between the groups at the cellular level
is striking. GB: Ginkgo biloba.

Table 2. Comparison of groups’ pre- and poststudy body and brain weights (values are given as mean ± SD).
Prestudy

Poststudy

n

Body weight (g)

n

Body weight (g)

Brain weight (mg)

Control

6

227.00 ± 19.49

6

241.83 ± 20.10

1.43 ± 0.07

Ischemia

6

245.67 ± 36.33

5

240.33 ± 31.05

1.40 ± 0.05

Ischemia + Ginkgo biloba

6

236.40 ± 20.23

5

226.00 ± 21.65

1.37 ± 0.04

Sham

6

225.00 ± 38.34

6

235.67 ± 37.31

1.42 ± 0.07

Group

4. Discussion
Cerebral ischemia is a significant cause of morbidity and
mortality in both childhood and adulthood within a wide
spectrum of neurological disorders. In cerebral ischemia,
a series of events take place, beginning with a depletion of
oxygen and energy sources such as ATP and glucose as a
result of a decrease in or complete interruption of cerebral
blood flow for various etiological reasons and ending in
degeneration in the neurons (2). Various drugs, such as
antiedema therapy, calcium channel blockers, free radical
scavengers, and glutamate receptor antagonists are used in
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order to prevent or eliminate injury arising after ischemia
(3,25).
While the mechanisms responsible for cell loss during
cerebral ischemia are not yet fully understood, much
important work has been done on the subject in recent years
(8,26). Histopathological studies performed with a cerebral
ischemia model have determined pronounced contraction
in neurons, irregularities in cell and nuclear margins, and
perineural and pericapillary edema. Some of these studies
reported a decrease in cerebral cortex and hippocampus
neuron numbers and infarct in the area of ischemia (27,28).

AKTÜRK et al. / Turk J Med Sci
Table 3. Section number used in the calculation of volume for each rat in the study groups, brain volume for each animal, and mean
brain volume (MBV) value for each group.
Group

Control (n = 6)

Ischemia (n = 5)

Ischemia +
Ginkgo biloba (n = 6)

Sham (n = 6)

Animal no.

Section number

Volume (mm3)

1

41

4.57

2

47

4.49

3

40

4.76

4

41

4.36

5

44

4.61

6

46

4.80

1

48

4.75

2

46

5.23

3

45

5.17

4

43

4.50

5

41

5.03

1

44

5.14

2

44

5.01

3

43

4.98

4

45

5.03

5

41

4.61

1

49

4.93

2

44

5.28

3

46

5.11

4

45

4.85

5

41

5.20

6

44

4.76

MBV (mean ± SD)

4.60 ± 0.16

4.93 ± 0.30

4.94 ± 0.18

5.02 ± 0.20*

*: P = 0.009, sham group vs. control group.

A very few studies have shown that GB has a protective
effect against ischemia-associated damage in neurons.
Some studies on the subject have established that GB
reduces cortical infarct volume in cerebral ischemia by
increasing blood flow (6). Some studies have suggested
that GB causes vascular dilatation by inhibiting nitric oxide
and thus protecting against hypoxic injury by permitting
an increase in blood flow (29,30), and that it improves
brain metabolism (31). One study maintained that GB
affected cerebral energy metabolism in rats exposed to
low-pressure hypoxia and could prolong survival times
(32). Some studies have identified an increase in brain
glucose levels. Similar experimental studies have shown
that GB produces a rise in blood glucose levels. The effect

of GB on the lactate/pyruvate ratio in the hypoxic rat brain
has been shown to be more pronounced than its effect on
lactate concentration. A significant fall in this ratio takes
place thanks to a decrease in pyruvate, particularly in
brains administered GB (33).
GB possesses powerful free radical-scavenging activity
and antioxidant effects. One study has suggested that GB
acts as a mediator on the Akt signaling pathway (34).
Studies have also reported that the volume of cerebral
infarct developing after focal cerebral ischemia decreased
significantly with administration of GB, and that GB
therapy mediated this effect by increasing antiapoptotic
signals between the Akt and subsignal pathway (35–37).
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Our study results showed that total sham group brain
volumes increased compared to the control group, and
that this increase was statistically significant. This may be
interpreted as the surgical stress that we induced in the rats
causing a rise in brain volume, and this increase still persisting
on the 14th day. However, this result was also unexpected,
and we encountered no findings in the literature to support
it. Apart from this finding, no significant relationship was
observed between the groups. Our examination of previous
studies showed that the absence of a significant correlation
between Group II and Group III or between Group III and
Group IV was an expected outcome. This is because earlier
studies have reported that GB has a neuroprotective effect
against permanent and temporary focal cerebral ischemia
(32), that it protects hippocampal neurons against cell
death (38), and that it has beneficial effects on various
neurodegenerative disorders and peripheral arterial
obstruction diseases (34,39). This may be interpreted as GB
protecting the brain against injuries that may develop in the
brain as a result of ischemia or being effective in overcoming
existing injury.

However, while the absence of any difference in
brain volume between Group III and Group II may be
interpreted as GB eliminating injury in the ischemia
region by initiating neurogenesis, it may also suggest that
ischemia may also have eliminated injury in the ischemia
region by initiating neurogenesis. To put it another way,
it may be deduced from this finding that GB may have
no effect on ischemia, because ischemia is already known
to trigger neurogenesis (40). We observed no significant
difference between the groups in terms of rat body weights
before and after the study. There was also no statistically
significant difference when the groups were analyzed in
terms of brain weight. This shows that neither ischemia
nor GB have any effect on rats’ weights.
In conclusion, it is possible that surgical stress can
increase brain volume, and that GB may have a protective
effect on brain volume in rats with occluded arteria carotis
communis blood flow. However, this is a stereological
volume study (41,42) and the results therefore need to
be supported with other research at the cellular level in
particular.
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